|
|
News Breaks | | | | September 18, 2012 | | 08:37 EDT |  | TRGT | Targacept may have Alzheimers treatment in pipeline, The Street says
Targacept (TRGT) has a drug in its pipeline that could one day treat Alzheimers and maybe schizophrenia, reports The Street. Even though one of its clinical trials ended in failure Monday, Fidelity Investments and BVF Partners are buying more shares of the company. Reference Link | |
|
News For TRGT From The Last 14 Days Check below for free stories on TRGT the last two weeks. |
|
|
| May 7, 2013 | | 07:41 EDT |  | TRGT | Targacept reports Q1 EPS (24c), consensus (34c)
Reports Q1 revenue $3.5M, consensus $600,000. | |
|
|
|
|
|
|
